Expression of multidrug resistance (P-glycoprotein) MDR1 and MDR2 genes in human hepatocellular carcinomas and liver metastases of colonic tumors

L. D. Teeter, H. C. Hsu, S. A. Curley, M. J. Tong, M. Tien Kuo

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Abstract

Overexpression of P-glycoproteins (P-gp), encoded by multidrug resistance (MDP) genes is responsible for multidrug resistance in animal cells. We analyzed the expression of MDR genes in human hepatocellular carcinomas (HCC) and liver metastases of colon tumors by an RNase protection assay. Our results indicated that both genes were not consistently overexpressed in these tumors, whereas MDR2 is often underexpressed in the metastatic tumors. Invasion of colon tumors to livers decreased MDR1 expression. These data suggest differential regulation mechanisms for the expression of MDR1 and MDR2 genes in these tumors, and a complex drug-resistance mechanism for liver cancers.

Original languageEnglish (US)
Pages (from-to)73-80
Number of pages8
JournalInternational journal of oncology
Volume2
Issue number1
DOIs
StatePublished - 1993

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Expression of multidrug resistance (P-glycoprotein) MDR1 and MDR2 genes in human hepatocellular carcinomas and liver metastases of colonic tumors'. Together they form a unique fingerprint.

Cite this